Cachexia and Chronic Disease

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Chronic Care".

Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 2232

Special Issue Editors


E-Mail Website
Guest Editor
School of Nursing and Midwifery, Queen’s University Belfast, Belfast BT9 7BL, UK
Interests: cancer; palliative care; patient and lay carer experience; mixed methods research; renal; cachexia
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Nursing and Midwifery, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK
Interests: cachexia, psychosocial support; quality of life; palliative care; renal; mixed methods; Patient and Public Involvement and Engagement (PPIE)

Special Issue Information

Dear Colleagues,

This Special Issue of Healthcare will focus on cachexia and chronic disease.

Cachexia is characterized by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) and progressive functional impairment that cannot be fully reversed by conventional nutritional support alone. Cachexia has a devastating physical and psychological effect on patients and caregivers, resulting in altered body image, reduced quality of life, and decreased physical function. It is often associated with the end of life.

Cachexia is reported in almost all chronic diseases at the advanced stages including cardiac disease, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis (RA), and chronic kidney disease (CKD).  The prevalence of cachexia varies depending on the diagnostic criteria used: 5–15% in cardiac disease, 5–15% in COPD, 15–32% in RA, 50–75% in CKD, and between 60% and 80% in cancer patients, and exceeds 80% in the last 1–2 weeks of life. It is a complex metabolic and multifactorial syndrome requiring early intervention and multimodal management. Currently, there is no standardized treatment for cachexia management.

This Special Issue will feature original and interesting clinical studies, reviews, short reports, narratives, and opinion pieces pertaining to this research topic. Potential topics include:

  • Issues related to cachexia management in chronic disease for patients, carers and/or healthcare staff.
  • Specific learning points for multidisciplinary healthcare practitioners working in cachexia management in chronic disease.
  • Multimodal cachexia management approaches for patients and/or families.
  • Integrated psychosocial care for patients living with cachexia and chronic disease and/or their families.

Prof. Dr. Joanne Reid
Dr. Carolyn Blair
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cachexia
  • chronic disease
  • end-stage disease
  • palliative care
  • multi-morbidity
  • frailty
  • older age
  • multimodal interventions

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

25 pages, 1173 KiB  
Article
Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change
by Carolyn Blair, Adrian Slee, Andrew Davenport, Denis Fouque, William Johnston, Kamyar Kalantar-Zadeh, Peter Maxwell, Clare McKeaveney, Robert Mullan, Helen Noble, Sam Porter, David Seres, Joanne Shields, Ian Swaine, Miles Witham and Joanne Reid
Healthcare 2022, 10(12), 2344; https://doi.org/10.3390/healthcare10122344 - 22 Nov 2022
Cited by 2 | Viewed by 1814
Abstract
In this study, we aimed to develop a theoretical framework for a multimodal, integrative, exercise, anti-inflammatory and dietary counselling (MMIEAD) intervention for patients with renal cachexia with reference to how this addresses the underlying causal pathways for renal cachexia, the outcomes anticipated, and [...] Read more.
In this study, we aimed to develop a theoretical framework for a multimodal, integrative, exercise, anti-inflammatory and dietary counselling (MMIEAD) intervention for patients with renal cachexia with reference to how this addresses the underlying causal pathways for renal cachexia, the outcomes anticipated, and how these will be evaluated. We used a Theory of Change (ToC) approach to guide six steps. Step 1 included inputs from a workshop to obtain key stakeholder views on the potential development of a multimodal intervention for renal cachexia. Step 2 included the findings of a mixed-methods study with Health Care Practitioners (HCPs) caring for individuals with End Stage Kidney Disease (ESKD) and cachexia. Step 3 included the results from our systematic literature review on multimodal interventions for cachexia management. In step 4, we used the body of our research team’s cachexia research and wider relevant research to gather evidence on the specific components of the multimodal intervention with reference to how this addresses the underlying causal pathways for renal cachexia. In steps 5 and 6 we developed and refined the ToC map in consultation with the core research team and key stakeholders which illustrates how the intervention components of MMIEAD interact to achieve the intended long-term outcomes and anticipated impact. The results of this study provide a theoretical framework for the forthcoming MMIEAD intervention for those with renal cachexia and in subsequent phases will be used to determine whether this intervention is effective. To the best of our knowledge no other multimodal intervention trials for cachexia management have reported a ToC. Therefore, this research may provide a useful framework and contribute to the ongoing development of interventions for cachexia management. Full article
(This article belongs to the Special Issue Cachexia and Chronic Disease)
Show Figures

Figure 1

Back to TopTop